SS
INMB icon

SBI Securities’s INmune Bio INMB Stock Holding History

SBI Securities’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$941 Hold
833
– – ﹤0.01% 2678
2025
Q4 		$1.3K Sell
833
-4,715
-85% -$8.41K ﹤0.01% 2547
2025
Q3 		$11.5K Buy
5,548
+3,915
+240% +$8.96K ﹤0.01% 1707
2025
Q2 		$3.77K Sell
1,633
-11
-0.7% -$81 ﹤0.01% 2120
2025
Q1 		$12.8K Sell
1,644
-27
-2% -$214 ﹤0.01% 1503
2024
Q4 		$7.8K Buy
+1,671
New +$8.71K ﹤0.01% 1747

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBI Securities's INMB Position: Q1 2026 in Review

SBI Securities held its INmune Bio (INMB) position steady in Q1 2026 at 833 shares worth $941. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

SBI Securities first reported a position in INMB in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.8K in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • SBI Securities held 833 shares of INmune Bio worth $941 as of Q1 2026.
  • SBI Securities left its INmune Bio share count unchanged in Q1 2026.
  • INmune Bio made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2678 holding.
  • SBI Securities first reported a position in INmune Bio in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's INmune Bio position peaked at $12.8K in Q1 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.